AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABBV
  4. [Form 4] ABBVIE INC. Insider Trading Activity

[Form 4] ABBVIE INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Potbelly Corporation (PBPB) 鈥� Form 4 filing: President & CEO Robert D. Wright reported three Code F transactions on 06/30/2025. Code F denotes shares surrendered to the issuer to cover tax obligations arising from the vesting of previously granted restricted stock units (RSUs).

  • Shares withheld: 1,004, 537 and 641, totaling 2,182 common shares at an indicated price of $12.25.
  • Post-transaction ownership: 780,254 common shares held directly.
  • Context: The surrendered shares represent tax-related withholding, not open-market sales, and reduce Mr. Wright鈥檚 stake by a small fraction relative to his overall holdings.

No derivative security activity was reported, and there were no purchases or sales for investment purposes. The filing is routine and conveys minimal impact on Potbelly鈥檚 share-count or insider ownership profile.

Potbelly Corporation (PBPB) 鈥� Comunicazione Form 4: Il Presidente e CEO Robert D. Wright ha segnalato tre transazioni di tipo Code F il 30/06/2025. Il codice F indica azioni consegnate all'emittente per coprire obblighi fiscali derivanti dal consolidamento di unit脿 azionarie vincolate (RSU) precedentemente assegnate.

  • Azioni trattenute: 1.004, 537 e 641, per un totale di 2.182 azioni ordinarie a un prezzo indicativo di $12,25.
  • Possesso dopo la transazione: 780.254 azioni ordinarie detenute direttamente.
  • Contesto: Le azioni cedute rappresentano una trattenuta fiscale e non una vendita sul mercato aperto, riducendo la partecipazione di Mr. Wright solo marginalmente rispetto al suo totale di azioni.

Non sono state segnalate attivit脿 su strumenti derivati n茅 acquisti o vendite a scopo di investimento. La comunicazione 猫 di routine e ha un impatto minimo sul numero di azioni di Potbelly o sul profilo di propriet脿 interna.

Potbelly Corporation (PBPB) 鈥� Presentaci贸n Formulario 4: El presidente y CEO Robert D. Wright report贸 tres transacciones con c贸digo F el 30/06/2025. El c贸digo F indica acciones entregadas al emisor para cubrir obligaciones fiscales derivadas del otorgamiento de unidades restringidas de acciones (RSU) previamente concedidas.

  • Acciones retenidas: 1,004, 537 y 641, sumando un total de 2,182 acciones comunes a un precio indicado de $12.25.
  • Propiedad tras la transacci贸n: 780,254 acciones comunes en propiedad directa.
  • Contexto: Las acciones entregadas representan una retenci贸n fiscal, no ventas en el mercado abierto, y reducen la participaci贸n de Mr. Wright en una fracci贸n peque帽a respecto a su tenencia total.

No se report贸 actividad con valores derivados ni compras o ventas para inversi贸n. La presentaci贸n es rutinaria y tiene un impacto m铆nimo en el n煤mero de acciones de Potbelly o en el perfil de propiedad interna.

Potbelly Corporation (PBPB) 鈥� Form 4 鞁犼碃: 靷灔 瓴� CEO鞚� Robert D. Wright臧� 2025雲� 6鞗� 30鞚检棎 靹� 瓯挫潣 Code F 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. Code F電� 鞚挫爠鞐� 攵�鞐悳 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 甓岆Μ 頇曥爼鞐� 霐半ジ 靹戈笀 鞚橂毳� 於╇嫻頃橁赴 鞙勴暣 氚滍枆靷棎 欤检嫕鞚� 氚橅櫂頃� 瓴冹潉 鞚橂頃╇媹雼�.

  • 氤措霅� 欤检嫕 靾�: 1,004欤�, 537欤�, 641欤茧 齑� 2,182欤检潣 氤错喌欤检澊氅�, 響滌嫓 臧�瓴╈潃 欤茧嫻 $12.25鞛呺媹雼�.
  • 瓯半灅 頉� 氤挫湢 欤检嫕: 歆侅爲 氤挫湢頃� 氤错喌欤� 780,254欤检瀰雼堧嫟.
  • 靸來櫓 靹る獏: 氚橅櫂霅� 欤检嫕鞚� 靹戈笀 鞗愳矞歆曥垬 氇╈爜鞙茧 鞚措（鞏挫 瓴冹澊氅�, 瓿店皽 鞁滌灔鞐愳劀鞚� 毵り皝鞚� 鞎勲媹氙�搿� Wright 靷灔鞚� 鞝勳泊 氤挫湢 欤检嫕 雽�牍� 鞎勳＜ 鞛戩潃 牍勳湪毵� 臧愳唽頃� 瓴冹瀰雼堧嫟.

韺岇儩靸來拡 甏�霠� 頇滊彊鞚� 氤搓碃霅橃 鞎婌晿鞙茧┌, 韴瀽 氇╈爜鞚� 毵れ垬 霕愲姅 毵る弰霃� 鞐嗢棃鞀惦媹雼�. 鞚措矆 鞁犼碃電� 鞚检儊鞝侅澑 瓴冹溂搿� Potbelly鞚� 欤检嫕 靾橂倶 雮措秬鞛� 氤挫湢 順勴櫓鞐� 氙胳箻電� 鞓來枼鞚� 氙鸽頃╇媹雼�.

Potbelly Corporation (PBPB) 鈥� D茅claration Formulaire 4 : Le pr茅sident et PDG Robert D. Wright a d茅clar茅 trois transactions de type Code F le 30/06/2025. Le Code F d茅signe des actions remises 脿 l'茅metteur pour couvrir les obligations fiscales li茅es 脿 la lev茅e de restrictions sur des unit茅s d'actions restreintes (RSU) pr茅c茅demment attribu茅es.

  • Actions retenues : 1 004, 537 et 641, soit un total de 2 182 actions ordinaires 脿 un prix indiqu茅 de 12,25 $.
  • Possession apr猫s transaction : 780 254 actions ordinaires d茅tenues directement.
  • Contexte : Les actions remises correspondent 脿 une retenue fiscale et non 脿 une vente sur le march茅 ouvert, r茅duisant la participation de M. Wright de fa莽on marginale par rapport 脿 son portefeuille global.

Aucune activit茅 sur instruments d茅riv茅s n鈥檃 茅t茅 signal茅e, ni achats ou ventes 脿 des fins d鈥檌nvestissement. La d茅claration est de routine et a un impact minimal sur le nombre d鈥檃ctions de Potbelly ou sur le profil de d茅tention des initi茅s.

Potbelly Corporation (PBPB) 鈥� Form 4 Meldung: Pr盲sident und CEO Robert D. Wright meldete am 30.06.2025 drei Code-F-Transaktionen. Code F steht f眉r Aktien, die dem Emittenten zur Abdeckung von Steuerverpflichtungen im Zusammenhang mit der Vesting von zuvor gew盲hrten Restricted Stock Units (RSUs) 眉bergeben wurden.

  • Einbehaltene Aktien: 1.004, 537 und 641, insgesamt 2.182 Stammaktien zu einem angegebenen Preis von 12,25 USD.
  • Besitz nach der Transaktion: Direkt gehaltene 780.254 Stammaktien.
  • Kontext: Die 眉bergebenen Aktien stellen eine steuerliche Einbehaltung dar, keine Verk盲ufe am offenen Markt, und reduzieren Herrn Wrights Beteiligung nur geringf眉gig im Verh盲ltnis zu seinem Gesamtbestand.

Es wurden keine Aktivit盲ten mit Derivaten gemeldet, ebenso keine K盲ufe oder Verk盲ufe zu Investitionszwecken. Die Meldung ist routinem盲脽ig und hat minimale Auswirkungen auf die Aktienanzahl von Potbelly oder das Insiderbesitzprofil.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding; negligible ownership change; neutral governance signal.

The Form 4 shows Mr. Wright surrendered 2,182 shares to settle RSU-related taxes. Code F transactions are internally net-settled and do not convey market sentiment. His direct stake remains substantial at 780,254 shares, reinforcing alignment with shareholders. From a governance standpoint, the disclosure is timely and complete, but it lacks material significance to valuation or control.

TL;DR: Non-market disposal of ~0.3% holdings; valuation impact immaterial.

Because the shares were withheld by the company, no market supply was created. At $12.25, the $26.7k notional value is trivial versus Potbelly鈥檚 daily volume and Mr. Wright鈥檚 remaining position. Investors should view the event as administrative rather than indicative of insider sentiment or operational trends.

Potbelly Corporation (PBPB) 鈥� Comunicazione Form 4: Il Presidente e CEO Robert D. Wright ha segnalato tre transazioni di tipo Code F il 30/06/2025. Il codice F indica azioni consegnate all'emittente per coprire obblighi fiscali derivanti dal consolidamento di unit脿 azionarie vincolate (RSU) precedentemente assegnate.

  • Azioni trattenute: 1.004, 537 e 641, per un totale di 2.182 azioni ordinarie a un prezzo indicativo di $12,25.
  • Possesso dopo la transazione: 780.254 azioni ordinarie detenute direttamente.
  • Contesto: Le azioni cedute rappresentano una trattenuta fiscale e non una vendita sul mercato aperto, riducendo la partecipazione di Mr. Wright solo marginalmente rispetto al suo totale di azioni.

Non sono state segnalate attivit脿 su strumenti derivati n茅 acquisti o vendite a scopo di investimento. La comunicazione 猫 di routine e ha un impatto minimo sul numero di azioni di Potbelly o sul profilo di propriet脿 interna.

Potbelly Corporation (PBPB) 鈥� Presentaci贸n Formulario 4: El presidente y CEO Robert D. Wright report贸 tres transacciones con c贸digo F el 30/06/2025. El c贸digo F indica acciones entregadas al emisor para cubrir obligaciones fiscales derivadas del otorgamiento de unidades restringidas de acciones (RSU) previamente concedidas.

  • Acciones retenidas: 1,004, 537 y 641, sumando un total de 2,182 acciones comunes a un precio indicado de $12.25.
  • Propiedad tras la transacci贸n: 780,254 acciones comunes en propiedad directa.
  • Contexto: Las acciones entregadas representan una retenci贸n fiscal, no ventas en el mercado abierto, y reducen la participaci贸n de Mr. Wright en una fracci贸n peque帽a respecto a su tenencia total.

No se report贸 actividad con valores derivados ni compras o ventas para inversi贸n. La presentaci贸n es rutinaria y tiene un impacto m铆nimo en el n煤mero de acciones de Potbelly o en el perfil de propiedad interna.

Potbelly Corporation (PBPB) 鈥� Form 4 鞁犼碃: 靷灔 瓴� CEO鞚� Robert D. Wright臧� 2025雲� 6鞗� 30鞚检棎 靹� 瓯挫潣 Code F 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. Code F電� 鞚挫爠鞐� 攵�鞐悳 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 甓岆Μ 頇曥爼鞐� 霐半ジ 靹戈笀 鞚橂毳� 於╇嫻頃橁赴 鞙勴暣 氚滍枆靷棎 欤检嫕鞚� 氚橅櫂頃� 瓴冹潉 鞚橂頃╇媹雼�.

  • 氤措霅� 欤检嫕 靾�: 1,004欤�, 537欤�, 641欤茧 齑� 2,182欤检潣 氤错喌欤检澊氅�, 響滌嫓 臧�瓴╈潃 欤茧嫻 $12.25鞛呺媹雼�.
  • 瓯半灅 頉� 氤挫湢 欤检嫕: 歆侅爲 氤挫湢頃� 氤错喌欤� 780,254欤检瀰雼堧嫟.
  • 靸來櫓 靹る獏: 氚橅櫂霅� 欤检嫕鞚� 靹戈笀 鞗愳矞歆曥垬 氇╈爜鞙茧 鞚措（鞏挫 瓴冹澊氅�, 瓿店皽 鞁滌灔鞐愳劀鞚� 毵り皝鞚� 鞎勲媹氙�搿� Wright 靷灔鞚� 鞝勳泊 氤挫湢 欤检嫕 雽�牍� 鞎勳＜ 鞛戩潃 牍勳湪毵� 臧愳唽頃� 瓴冹瀰雼堧嫟.

韺岇儩靸來拡 甏�霠� 頇滊彊鞚� 氤搓碃霅橃 鞎婌晿鞙茧┌, 韴瀽 氇╈爜鞚� 毵れ垬 霕愲姅 毵る弰霃� 鞐嗢棃鞀惦媹雼�. 鞚措矆 鞁犼碃電� 鞚检儊鞝侅澑 瓴冹溂搿� Potbelly鞚� 欤检嫕 靾橂倶 雮措秬鞛� 氤挫湢 順勴櫓鞐� 氙胳箻電� 鞓來枼鞚� 氙鸽頃╇媹雼�.

Potbelly Corporation (PBPB) 鈥� D茅claration Formulaire 4 : Le pr茅sident et PDG Robert D. Wright a d茅clar茅 trois transactions de type Code F le 30/06/2025. Le Code F d茅signe des actions remises 脿 l'茅metteur pour couvrir les obligations fiscales li茅es 脿 la lev茅e de restrictions sur des unit茅s d'actions restreintes (RSU) pr茅c茅demment attribu茅es.

  • Actions retenues : 1 004, 537 et 641, soit un total de 2 182 actions ordinaires 脿 un prix indiqu茅 de 12,25 $.
  • Possession apr猫s transaction : 780 254 actions ordinaires d茅tenues directement.
  • Contexte : Les actions remises correspondent 脿 une retenue fiscale et non 脿 une vente sur le march茅 ouvert, r茅duisant la participation de M. Wright de fa莽on marginale par rapport 脿 son portefeuille global.

Aucune activit茅 sur instruments d茅riv茅s n鈥檃 茅t茅 signal茅e, ni achats ou ventes 脿 des fins d鈥檌nvestissement. La d茅claration est de routine et a un impact minimal sur le nombre d鈥檃ctions de Potbelly ou sur le profil de d茅tention des initi茅s.

Potbelly Corporation (PBPB) 鈥� Form 4 Meldung: Pr盲sident und CEO Robert D. Wright meldete am 30.06.2025 drei Code-F-Transaktionen. Code F steht f眉r Aktien, die dem Emittenten zur Abdeckung von Steuerverpflichtungen im Zusammenhang mit der Vesting von zuvor gew盲hrten Restricted Stock Units (RSUs) 眉bergeben wurden.

  • Einbehaltene Aktien: 1.004, 537 und 641, insgesamt 2.182 Stammaktien zu einem angegebenen Preis von 12,25 USD.
  • Besitz nach der Transaktion: Direkt gehaltene 780.254 Stammaktien.
  • Kontext: Die 眉bergebenen Aktien stellen eine steuerliche Einbehaltung dar, keine Verk盲ufe am offenen Markt, und reduzieren Herrn Wrights Beteiligung nur geringf眉gig im Verh盲ltnis zu seinem Gesamtbestand.

Es wurden keine Aktivit盲ten mit Derivaten gemeldet, ebenso keine K盲ufe oder Verk盲ufe zu Investitionszwecken. Die Meldung ist routinem盲脽ig und hat minimale Auswirkungen auf die Aktienanzahl von Potbelly oder das Insiderbesitzprofil.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Alpern Robert J
(Last) (First) (Middle)
1 N. WAUKEGAN ROAD
(Street)
NORTH CHICAGO IL 60064
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Equivalent Units $185.62 06/30/2025 A 40 (1) (1) Common Stock 40 $185.62 10,038(2) D
Explanation of Responses:
1. Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
T.O. Odutayo, Attorney-in-Fact for Robert J. Alpern 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

Why did Potbelly CEO Robert D. Wright dispose of shares on 06/30/2025?

The 2,182 shares were withheld by the company to cover payroll taxes triggered by vested RSUs, not open-market sales.

How many Potbelly shares does the CEO hold after the Form 4 transactions?

Following the tax-withholding transactions, Mr. Wright directly owns 780,254 common shares.

What is a Code F transaction in an SEC Form 4 filing?

Code F indicates shares are surrendered to the issuer solely to pay tax withholding on equity awards.

Did the Form 4 report any derivative security exercises for Potbelly (PBPB)?

No. Table II shows no derivative securities acquired or disposed of during the period.

Is the insider activity in this Potbelly Form 4 considered material to investors?

Given the small share count and tax-related nature of the transactions, the impact is generally viewed as immaterial.
Stock ABBV logo
Abbvie Inc

NYSE:ABBV

ABBV Rankings

#27 Ranked by Market Cap
#972 Ranked by Dividends

ABBV Latest News

Jul 10, 2025
AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38脳BCMA脳CD3 Trispecific Antibody
Jun 30, 2025
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology
Jun 30, 2025
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUV脡DERM庐 for the Improvement of Neck Appearance
Jun 30, 2025
AbbVie to Host Second-Quarter 2025 Earnings Conference Call
Jun 20, 2025
AbbVie Declares Quarterly Dividend

ABBV Latest SEC Filings

Jul 7, 2025
[SCHEDULE 13G/A] ABBVIE INC. SEC Filing
Jul 3, 2025
[8-K] ABBVIE INC. Reports Material Event
Jul 2, 2025
[Form 4] ABBVIE INC. Insider Trading Activity
Jul 2, 2025
[Form 4] ABBVIE INC. Insider Trading Activity

ABBV Stock Data

334.34B
1.76B
0.12%
74.08%
1.05%
Drug Manufacturers - General
Pharmaceutical Preparations
United States
NORTH CHICAGO